优化皮膜黑色素瘤的TIL治疗:从皮肤黑色素瘤中吸取的教训和不吸取的教训
Shravan Leonard-Murali1,2,3,4, Udai S Kammula1,2,3
1Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Immunotherapy
|March 18, 2025
概括
瘤透淋巴细胞采用细胞疗法 (TIL-ACT) 显示出超越皮肤黑色素瘤的前景,目前正在进行的研究正在探索其在转移性阴膜黑色素瘤中的应用. 本综述详细介绍了TIL-ACT的发展及其对免疫疗法耐药瘤的潜力.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- 瘤透淋巴细胞的采用转移 (TIL-ACT) 是一种个性化免疫疗法,利用活体扩大瘤居住的T细胞.
- Lifileucel是一种自身的TIL产品,在2024年获得了FDA的批准,用于晚期皮肤黑色素瘤 (CM).
- 在其他固体瘤中TIL-ACT的疗效,特别是免疫性较低的瘤,仍然在很大程度上未被探索.
研究的目的:
- 审查TIL-ACT在晚期皮肤黑色素瘤的历史发展和临床结果.
- 探索TIL-ACT在转移性乳膜黑色素瘤 (UM) 的新型应用,这是一种耐免疫治疗的癌症.
- 突出CM和UM之间影响TIL制造和精准医学策略的生物学区别.
主要方法:
- 对皮肤黑色素瘤中TIL-ACT的历史数据和临床结果的审查.
- 皮肤黑色素瘤和皮膜黑色素瘤之间的生物差异分析.
- 对UM特定TIL产品的制造考虑和生物标志物开发进行讨论.
主要成果:
- TIL-ACT是一种已批准用于晚期皮肤黑色素瘤的治疗方法.
- 由于其免疫生物学的特点,Uveal黑色素瘤对TIL-ACT提出了独特的挑战.
- CM和UM之间的差异影响了TIL产品生成和治疗策略.
结论:
- TIL-ACT已经在皮肤黑色素瘤中取得了成功.
- 需要进一步的研究,以适应TIL-ACT用于免疫疗法耐药的瘤,如皮膜黑色素瘤.
- 精准医学方法,包括生物标志物开发,对于推进转移性皮膜黑色素瘤的TIL-ACT至关重要.
相关概念视频
Tumor Immunotherapy
454
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
454
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Skin Cancer
3.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K


